Recurrent Respiratory Papillomatosis (Juvenile Laryngeal Papilloma or Laryngeal Papilloma) drugs in development, 2023

GlobalData tracks 6 drugs in development for Recurrent Respiratory Papillomatosis (Juvenile Laryngeal Papilloma or Laryngeal Papilloma) by six companies/universities/institutes. The top development phase for Recurrent Respiratory Papillomatosis (Juvenile Laryngeal Papilloma or Laryngeal Papilloma) is phase ii, with three drugs in that stage.

Source link
#Recurrent #Respiratory #Papillomatosis #Juvenile #Laryngeal #Papilloma #Laryngeal #Papilloma #drugs #development